Communiqués Avenir Wellness Solutions, Inc.

Actions

AVRW

US23127P1049

Marché Fermé - OTC Markets Autres places de cotation 19:56:43 28/06/2024			Varia. 5j.	Varia. 1 janv.
0,0519 ^USD	+3,80 %		+4,01 %	-30,24 %

30/05	Avenir Wellness Solutions, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
17/05	Avenir Wellness Solutions, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avenir Wellness Solutions Reports Second Quarter 2023 Results	16/08/23	AQ
Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year over Year Revenue Increases and Continued High Gross Margins	01/08/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22/05/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	20/04/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	19/04/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	08/03/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	17/01/23	AQ
CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21/11/22	AQ
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference	11/11/22	NE
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV	24/10/22	NE
Cure Pharmaceutical Reports Second Quarter 2022 Results with Increased Sequential Revenues and Strong Margins	05/09/22	AQ
CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	02/09/22	AQ
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	02/09/22	GL
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	02/09/22	AQ
CURE PHARMACEUTICAL HOLDING CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/08/22	AQ
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	16/08/22	GL
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	16/08/22	AQ
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	09/08/22	GL
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	09/08/22	AQ
CURE Pharmaceutical Announces the Appointment of New Board Member	02/08/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Avenir Wellness Solutions, Inc.

Actions

AVRW

US23127P1049

Communiqués

Filtres